Report Categories
View AllRecent Articles
View All
Should I Hold Sangamo Therapeutics Sgmo Stock Now Price At 0.30 Up 1.13 20260406
Is Osprey Obtc Stock Competitive Now Price At 22.25 Up 4.58 20260406
Can Cardio Diag Cdiow Stock Maintain Growth Price At 0.01 Down 4.49 20260408
BRX Brixmor Q1 earnings smash expectations with 63 EPS beat but investors remain cautious despite results
Grab GRAB Stock IV Percentile 473 20260418
RF Regions Financial Corporation reports Q4 2025 EPS shortfall alongside 62 percent annual revenue growth shares edge higher
Evotec SE EVO Surges 216 Nearing 298 Resistance 20260520
Elemental ELE Q1 2026 Results Fall Short EPS 002 Revenue NA
Japan Banks Prepare for MythosLinked Cyberattacks Ahead of Fall 2026
Japanese Megabanks Post Record Profits but Analysts Warn of Slowing Growth Amid Rising Risks
Microsofts Anthropic Partnership Could Deliver 43 Billion Azure Revenue by 2030 HSBC Estimates
Stocks Surge Oil and Dollar Retreat Amid Renewed Middle East Peace Hopes
US Retail Sales Data Indicates Consumer Resilience Amid Persistent Cost Pressures
Samsung Strike Suspended as Workers Vote on Tentative Deal Involving AI Bonus Demand
Bata India Targets 3000 Stores Accelerates Digital Commerce and Premiumisation Push
Fair Isaac FICO Stock Analysis Analyst Estimates and Rating Trends
LE Q1 2026 Earnings Profit Miss Masks Operational Resilience
ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious
Core Natural Resources CNR Q1 2026 Earnings EPS Beats Estimates by 136 Amid Quiet Market Response
PG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains 317
New England Realty Associates NEN Q4 2024 Earnings Partnership Reports Strong Earnings Per Unit Stock Unchanged
GSK Q1 2026 Earnings EPS Surpasses Expectations Amid Solid Operational Performance
Allot Ltd ALLT Faces Resistance Near 8 After Modest Decline
Old Republic International ORI Slips 132 as Defensive Sectors Face ProfitTaking
IBEX Limited IBEX Edges Higher Testing Key Resistance at 3326
US Physical Therapy USPH Gains 332 as Stock Tests Resistance Levels
Scilex Holding SCLX Surges 587 as Momentum Builds Toward Resistance